The latest policies, articles, white papers, and more.
Enhancing clinician-patient interactions through targeted incentives may be a key strategy for improving healthcare quality and patient outcomes.
The FDA’s Breakthrough Device Designation faces challenges in aligning clinical evidence with Medicare reimbursement policies, slowing device access.
An outline of how current hospital safety procedures can be adapted to regulate AI technologies without compromising patient safety.
An analysis of historical data suggested adjusting payment policies to equalize reimbursement rates across different care settings may lead to significant cost savings.
The development of Mobile-CRISPRi provides a versatile approach to study gene function in bacterial pathogens, contributing to our understanding of infection and immunity.
The FDA's new guidance offers a framework for the development and evaluation of AI/ML-enabled medical devices, aiming to streamline the approval process.
Through a detailed examination of antibiotic development failures, the authors advocate for regulatory and market access reforms to accelerate the availability of effective treatments for Gram-negative infections.
Examining the prevalence of self-reported disabilities among U.S. medical students reveals gaps in accommodations and the need for more inclusive support systems.
Rubrum Advising